| 2019 | The clinical implications of FDG-PET/CT differ according to histology in advanced gastric cancer.
| 노성훈, 라선영, 안중배, 윤미진, 조응혁, 형우진 | Article |
| 2019 | Mesothelin Expression Is a Predictive Factor for Peritoneal Recurrence in Curatively Resected Stage III Gastric Cancer | 김민환, 김현기, 남정모, 라선영, 신수진, 정민규, 정현철, 최윤영, 최혜진 | Article |
| 2019 | Significance of Metabolic Tumor Volume and Total Lesion Glycolysis Measured Using ¹⁸F-FDG PET/CT in Locally Advanced and Metastatic Gallbladder Carcinoma
| 라선영, 박형순, 이재훈, 전태주, 정희철, 최혜진 | Article |
| 2019 | A phase I/II study of poziotinib combined with paclitaxel and trastuzumab in patients with HER2-positive advanced gastric cancer | 라선영, 조재용 | Article |
| 2019 | Tumor microenvironment dictates regulatory T cell phenotype: Upregulated immune checkpoints reinforce suppressive function
| 김가민, 김혜련, 라선영, 박성용, 심효섭, 윤홍인, 이진구, 정경영, 조남훈, 조병철 | Article |
| 2019 | S-1 Based Doublet as an Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer: Results from the Randomized Phase III POST Trial
| 김효송, 노성훈, 라선영, 정민규, 정인경, 정재호, 정현철, 형우진 | Article |
| 2019 | Avelumab (anti-PD-L1) as first-line switch-maintenance or second-line therapy in patients with advanced gastric or gastroesophageal junction cancer: phase 1b results from the JAVELIN Solid Tumor trial
| 라선영, 정현철 | Article |
| 2019 | Phase II trial of preoperative sequential chemotherapy followed by chemoradiotherapy for high-risk gastric cancer | 강버들, 금웅섭, 김은혜, 김현기, 김형일, 김효송, 노성훈, 라선영, 박준철, 범승훈, 손태일, 신성관, 이상길, 이용찬, 임준석, 장지석, 정민규, 정인경, 정재호, 정현수, 정현철, 최윤영, 형우진 | Article |
| 2019 | Landscape of Actionable Genetic Alterations Profiled from 1,071 Tumor Samples in Korean Cancer Patients
| 김상겸, 라선영, 정현철 | Article |
| 2019 | Immunohistochemistry Biomarkers Predict Survival in Stage II/III Gastric Cancer Patients: From a Prospective Clinical Trial
| 김민환, 김현기, 김형일, 김효송, 노성훈, 라선영, 박형순, 범승훈, 손태일, 정민규, 정인경, 정재호, 정현철, 최윤영, 형우진 | Article |
| 2019 | Differences in the Efficacies of Pazopanib and Gemcitabine/Docetaxel as Second-Line Treatments for Metastatic Soft Tissue Sarcoma | 김경식, 김상겸, 김성훈, 김승현, 김지형, 김효송, 노성훈, 라선영, 박형순, 서진석, 신규호, 안중배, 이영한, 정현철, 최영득, 한정우, 허수진, 허혁 | Article |
| 2019 | Behaviors and Attitudes toward the Use of Complementary and Alternative Medicine among Korean Cancer Patients
| 라선영, 정현철 | Article |
| 2019 | Characteristics and Treatment Patterns of Patients with Advanced Soft Tissue Sarcoma in Korea
| 김효송, 남정모, 라선영, 한민경 | Article |
| 2019 | Comprehensive immune profiling and immune-monitoring using body fluid of patients with metastatic gastric cancer
| 김태수, 김효송, 라선영, 박준용, 범승훈, 이충근, 정민규, 정현철 | Article |
| 2019 | Inhibiting casein kinase 2 overcomes paclitaxel resistance in gastric cancer | 김태수, 김효송, 라선영, 박규현, 범승훈, 장향란, 정민규, 정재호, 정현철 | Article |
| 2019 | Randomised phase II trial comparing four front-line doublets in Asian patients with metastatic gastric cancer | 강버들, 김효송, 남정모, 라선영, 정민규, 정현철 | Article |
| 2019 | EORTC-1203-GITCG - the "INNOVATION"-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group
| 라선영 | Article |
| 2019 | Stability of symptom clusters and sentinel symptoms during the first two cycles of adjuvant chemotherapy | 라선영 | Article |
| 2019 | Temsirolimus in Asian Metastatic/Recurrent Non-clear Cell Renal Carcinoma
| 강버들, 남정모, 라선영, 정현철, 조남훈 | Article |
| 2018 | MET in gastric cancer with liver metastasis: The relationship between MET amplification and Met overexpression in primary stomach tumors and liver metastasis. | 김한상, 김현기, 라선영, 정현철 | Article |
| 2018 | Renal Cell Carcinoma Is Abrogated by p53 Stabilization through Transglutaminase 2 Inhibition
| 라선영 | Article |
| 2018 | Real-Time Tumor Gene Expression Profiling to Direct Gastric Cancer Chemotherapy: Proof-of-Concept "3G" Trial | 김효송, 라선영, 정민규, 정현철 | Article |
| 2018 | Multidisciplinary treatment for patients with stage IV gastric cancer: the role of conversion surgery following chemotherapy
| 김형일, 김효송, 노성훈, 라선영, 백송이, 범승훈, 손태일, 임준석, 정민규, 정재호, 정희철, 최승호, 최윤영, 형우진 | Article |
| 2018 | Prognostic implications of polycomb proteins ezh2, suz12, and eed1 and histone modification by H3K27me3 in sarcoma.
| 김경식, 김성훈, 김은경, 김효송, 노성훈, 라선영, 서진석, 안중배, 이영한, 정현철, 최영득, 한정우, 허혁 | Article |
| 2018 | The Benefit of Pro Re Nata Antiemetics Provided With Guideline-Consistent Antiemetics in Delayed Nausea Control | 김건민, 김혜련, 라선영, 손주혁 | Article |
| 2018 | Rab25 augments cancer cell invasiveness through a beta1 integrin/EGFR/VEGF-A/Snail signaling axis and expression of fascin | 라선영, 정재호 | Article |
| 2018 | Forty-nine gastric cancer cell lines with integrative genomic profiling for development of c-MET inhibitor | 김태수, 라선영, 정현철, 정희철 | Article |
| 2018 | Retrospective analysis of palliative chemotherapy for the patients with bladder adenocarcinoma: Korean Cancer Study Group Genitourinary and Gynecology Cancer Committee.
| 김효송, 라선영 | Article |
| 2018 | The prognostic value of volume-based parameters using<sup>18</sup>F-FDG PET/CT in gastric cancer according to HER2 status | 김효송, 라선영, 박지수, 범승훈, 윤미진, 이충근, 정민규, 정현철, 조응혁 | Article |
| 2018 | A Prediction Model of Tumor Progression and Survival in HER2-Positive Metastatic Gastric Cancer Patients Treated with Trastuzumab and Chemotherapy | 김승섭, 김효송, 남정모, 라선영, 박경수, 정민규, 정재호, 정현철, 채동우 | Article |
| 2018 | Marked Loss of Muscle, Visceral Fat, or Subcutaneous Fat After Gastrectomy Predicts Poor Survival in Advanced Gastric Cancer: Single-Center Study from the CLASSIC Trial | 김지형, 김형일, 김효송, 노성훈, 라선영, 박형순, 백송이, 범승훈, 손태일, 임준석, 정민규, 정재호, 정현철, 최은아, 허수진, 형우진 | Article |
| 2018 | Efficacy and tolerability of ramucirumab monotherapy or in combination with paclitaxel in gastric cancer patients from the Expanded Access Program Cohort by the Korean Cancer Study Group (KCSG) | 강윤구, 라선영, 정민규, 조재용 | Article |
| 2018 | Genetic Alterations among Korean Melanoma Patients Showing Tumor Heterogeneity: A Comparison between Primary Tumors and Corresponding Metastatic Lesions.
| 노미령, 라선영, 신상준, 오병호, 이시형, 정기양 | Article |
| 2018 | BGJ398, A Pan-FGFR Inhibitor, Overcomes Paclitaxel Resistance in Urothelial Carcinoma with FGFR1 Overexpression
| 라선영, 안중배 | Article |
| 2018 | CpG Island Methylator Phenotype and Methylation of Wnt Pathway Genes Together Predict Survival in Patients with Colorectal Cancer
| 김남규, 김태일, 라선영, 박규현, 신상준, 안중배, 이강영 | Article |
| 2018 | Casein Kinase 2 Inhibitor, CX-4945, as a Potential Targeted Anticancer Agent in Gastric Cancer | 김태수, 라선영, 박규현, 정민규, 정현철 | Article |
| 2018 | Regulation of proliferation and invasion by the IGF signalling pathway in Epstein-Barr virus-positive gastric cancer
| 라선영, 정현철 | Article |
| 2018 | Outcomes based on prior therapy in the phase 3 METEOR trial of cabozantinib versus everolimus in advanced renal cell carcinoma | 라선영 | Article |
| 2018 | Reconsideration of sample size and power calculation for overall survival in cancer clinical trials
| 남정모, 라선영, 정인경 | Article |
| 2017 | Prevalence and prognostic implications of psychological distress in patients with gastric cancer
| 김건민, 김경란, 김혜련, 노성훈, 라선영, 송수경, 정현철 | Article |
| 2017 | A First-Time-in-Human Study of GSK2636771, a Phosphoinositide 3 Kinase Beta-Selective Inhibitor, in Patients with Advanced Solid Tumors | 라선영, 정현철 | Article |
| 2017 | Modulation of HAT activity by the BRCA2 N372H variation is a novel mechanism of paclitaxel resistance in breast cancer cell lines | 김태수, 라선영, 정현철, 정희철 | Article |
| 2017 | Complementary utility of targeted next-generation sequencing and immunohistochemistry panels as a screening platform to select targeted therapy for advanced gastric cancer
| 금웅섭, 김현기, 김형일, 김효송, 노성훈, 라선영, 박규현, 박준철, 배수진, 백순명, 범승훈, 손태일, 신성관, 이상길, 이용찬, 이은영, 이한나, 임준석, 정민규, 정재호, 정현철, 최윤영, 형우진 | Article |
| 2017 | Locoregional relapse after gastrectomy with D2 lymphadenectomy for gastric cancer | 금웅섭, 김효송, 노성훈, 라선영, 윤홍인, 이용찬, 임준석, 장지석, 형우진 | Article |
| 2017 | Cardiotoxicity of trastuzumab in patients with HER2-positive gastric cancer
| 강석민, 김지형, 김효송, 라선영, 박지수, 박형순, 범승훈, 심지영, 이충근, 정민규, 정현철, 허수진, 홍그루 | Article |
| 2017 | Characterizing the outcomes of metastatic papillary renal cell carcinoma | 라선영 | Article |
| 2017 | Symptom clusters during palliative chemotherapy and their influence on functioning and quality of life | 라선영 | Article |
| 2017 | Discontinuing VEGF-targeted Therapy for Progression Versus Toxicity Affects Outcomes of Second-line Therapies in Metastatic Renal Cell Carcinoma | 라선영 | Article |
| 2017 | Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC
| 라선영 | Article |
| 2017 | Integration of radiotherapy and chemotherapy for abdominal lymph node recurrence in gastric cancer | 금웅섭, 김효송, 라선영, 윤홍인, 이용찬, 임준석, 형우진 | Article |
http://orcid.org/0000-0002-2512-4531
(Yonsei Health Research Network)
(7006023235)
